About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Only 3% of medical oncologists in the United States are Black.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts outline benefits and detriments of COVID-19 vaccine mandates.
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.
A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.
More research is needed before radiomics can be used in clinical practice, according to researchers.
Experts review approved therapies and treatments still under investigation.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Metformin did not improve progression-free or overall survival in either study.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
The test can accurately detect cancer and predict where it is located, according to researchers.